Posts by Brian Howard Eisner, MD
Diabetes Not a Risk Factor for Septic Shock Among Patients With Ureteral Stone and UTI
Jason Lee, MD, Brian H. Eisner, MD, and colleagues found the quick Sequential Organ Failure Assessment (qSOFA) may demonstrate false-positive results in predicting septic shock among patients with diabetes who have ureteral stones and concomitant infection, and diabetes was not an overall risk factor for septic shock.
Pyelovenous Backflow During Flexible Ureteroscopy Is Influenced by Renal Pelvis Pressure
Christina Kottooran, MD, Brian H. Eisner, MD, and colleagues demonstrated in an in vivo porcine model that it may be possible to limit pyelovenous backflow (fluid absorption) during flexible ureteroscopy by managing renal pelvis pressure and the duration of the procedure.
Study Supports Use of Tranexamic Acid During Percutaneous Nephrolithotomy
David E. Hinojosa-González, MD, Brian H. Eisner, MD, colleagues determined that compared with placebo, the use of tranexamic acid during percutaneous nephrolithotomy is associated with improvements in operative time, change in hemoglobin, transfusion rate, complication rates, length of stay, and stone-free rates.
Review: Opioids and Kidney Stones
Brian H. Eisner, MD, and colleagues recently reviewed the use of opioids to treat renal colic and control pain after endoscopic kidney stone surgery. They focus on opioid alternatives and practice patterns that discourage persistent use of these medications.
Mass General Offers Novel, Kidney-saving Urothelial Cancer Treatment
Mitomycin chemoablation with a mitomycin gel, a novel treatment offered in the Department of Urology at Massachusetts General Hospital, can avoid the need for surgical removal of the kidney and ureter in patients with upper tract urothelial cancer.
Study Finds No Link Between Ureteral Access Sheaths and Ureteral Lesions
Research led by Brian Eisner, MD, co-director of the Kidney Stone Program at Massachusetts General Hospital, shows no risk of ureteral lesions with the use of ureteral access sheaths four years post-procedure.
Using qSOFA to Predict Sepsis after Percutaneous Nephrolithotomy
The quick Sequential Organ Failure Assessment is superior to the systemic inflammatory response syndrome criteria for predicting septic shock after percutaneous nephrolithotomy, according to the first study to compare them.
Patients Without Evidence of Ureteral Stone Passage Should Seek Follow-up Imaging
According to new research from urologists at Massachusetts General Hospital, cessation of pain does not necessarily indicate the passage of a ureteral stone.
New Model Predicts Renal Pelvis Pressures During Ureteroscopic Lithotripsy
In order to minimize the patient's risk of urosepsis, researchers at Massachusetts General Hospital are developing a web-based or mobile application that will help surgeons see how their proposed ureteroscopic lithotripsy technique for an individual patient will affect renal pelvis pressure.
Five Sessions to See at #AUA2019
The American Urological Association (AUA) is hosting its Annual Meeting in Chicago, IL from May 3-6, 2019. Specialists from the Massachusetts General Hospital Department of Urology will present on leading research and innovative treatment approaches. Mass General doctors will participate in over 20 different sessions covering the full spectrum of urologic care, including bladder, prostate, urologic oncology and more.
New Model Evaluates Cost-Effectiveness of Treatment Modalities for Ureteral Stones
After determining success rates of shock-wave lithotripsy and ureteroscopic laser lithotripsy, surgeons can use a new decision analysis model to see which procedure is more cost-effective at their respective institutions.
Dusting Vs. Basketing: Strategies for Disintegrating Renal Stones
Dusting, a new protocol for treating kidney stones using recent laser technologies, has proven to deliver successful patient outcomes equal to those of traditional basketing, according to a study by the Endourology Disease Group for Excellence.
Dr. Brian Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones and laparoscopic surgery. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease and surgical treatment of kidney stones.